LEVERnatx is a CNS/Neurological company that leverages RNA regulatory mechanisms to develop RNA-targeted therapeutics. They identify novel target RNA biology and design targeted therapeutics to increase, inhibit, or restore expression/protein function. They currently have 4 programs in CNS and related disease areas, with their lead program (L5001) going into IND in 2025.

Biotechnology Innovation Organization

LEVERnatx

BIO International Convention

World Congress on Industrial Biotechnology

BIO Business Solutions®

BIO Latin America Conference

BIO CEO & Investor Conference

BIO Investor Forum

Council of State Bioscience Associations (CSBA)

Working to Fight AMR

BIO Asia International Conference

BIO is the world's largest biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. Our mission is to be the champion of biotechnology and the advocate for our member organizations—both large and small.BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. We also represent state and regional biotech associations, service providers to the industry and academic centers.

ORG:BIO

LEVERnatx

locale

market

industry

website

crunchbase

linkedin

founding date

Metrics